THERAPEUTICSMD INC (TXMD) Stock Analyst Ratings
USA - NASDAQ:TXMD - US88338N2062 - Common Stock
1.96 USD
+0.34 (+20.99%)
1.87 USD
-0.09 (-4.59%)
ChartMill assigns a Buy % Consensus number of 43% to TXMD. The Buy consensus is the weighted average rating of the current analysts ratings.
TXMD was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TXMD.
In the previous month the buy percentage consensus was at a similar level.
TXMD was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-17 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-01-11 | Cantor Fitzgerald | Reiterate | Neutral |
| 2022-07-13 | Cantor Fitzgerald | Reiterate | Neutral |
| 2022-06-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-06 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-03-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-12 | HC Wainwright & Co. | Maintains | Buy |
THERAPEUTICSMD INC / TXMD FAQ
What is the consensus rating for THERAPEUTICSMD INC (TXMD) stock?
The consensus rating for THERAPEUTICSMD INC (TXMD) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for TXMD stock?
The number of analysts covering THERAPEUTICSMD INC (TXMD) is 6.